![Nagesh Mahanthappa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nagesh Mahanthappa
Président chez
Exo Therapeutics, Inc.
Profil
Nagesh K.
Mahanthappa is the founder of TwistDX, Inc. (founded in 2010) and TwistDX Ltd. (founded in 2002).
He currently holds the position of Executive Chairman at Exo Therapeutics, Inc. since 2023, Independent Director at Casma Therapeutics, Inc. since 2020, Non-Executive Director at Camena Bioscience Ltd. since 2016, and Independent Director at Abata Therapeutics, Inc. since 2021.
He has previously served as President, Chief Executive Officer & Director at Scholar Rock, Inc. from 2012 to 2020 and President, Chief Executive Officer & Director at Scholar Rock Holding Corp.
from 2021 to 2022.
Dr. Mahanthappa has also held positions at Medtronic, Inc., Merck & Co., Inc., Vertex Pharmaceuticals, Inc., Novartis AG, Ontogeny, Inc., Alnylam Pharmaceuticals, Inc., and Avila Therapeutics, Inc. He has a doctorate degree from the California Institute of Technology, an undergraduate degree from The University of Colorado, and an MBA from F.W.
Olin Graduate School of Business.
Postes actifs de Nagesh Mahanthappa
| Sociétés | Poste | Début |
|---|---|---|
Camena Bioscience Ltd.
 Camena Bioscience Ltd. BiotechnologyHealth Technology Operates as biotechnology company that produces long and complex synthetic genes | Directeur/Membre du Conseil | 01/11/2016 |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates MA-based biotechnology company harnessing natural cellular process of autophagy to design new medicines | Directeur/Membre du Conseil | 17/11/2020 |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Président | 04/01/2023 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Directeur/Membre du Conseil | - |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Directeur/Membre du Conseil | 29/07/2021 |
Anciens postes connus de Nagesh Mahanthappa
| Sociétés | Poste | Fin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Général | 20/10/2022 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur Général | 01/08/2020 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | 01/08/2020 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Directeur des opérations | 01/05/2012 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Nagesh Mahanthappa
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological diseases | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
TwistDX, Inc.
 TwistDX, Inc. Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Commercial Services |
F.W. Olin Graduate School of Business
 F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
TwistDx Ltd.
 TwistDx Ltd. BiotechnologyHealth Technology Provides molecular testing and technology | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Casma Therapeutics, Inc.
Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates MA-based biotechnology company harnessing natural cellular process of autophagy to design new medicines | Commercial Services |
Camena Bioscience Ltd.
Camena Bioscience Ltd. BiotechnologyHealth Technology Operates as biotechnology company that produces long and complex synthetic genes | Health Technology |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Health Technology |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Health Technology |
Choisissez Zonebourse 
